Includes technologies from the women’s and reproductive health spaces including infertility, contraception, gynecological disorders as well as female-specific cancers like ovarian, uterine, and breast.
Extirpative surgeries, radiation treatment, congenital anomalies, ovariectomy, menopause, aging, chemotherapy, and vaginal birth trauma can all result in loss or impairment of vaginal structure and function. Extirpative surgeries, radiation treatment, congenital anomalies, ovariectomy, menopause, aging, chemotherapy, and vaginal birth trauma can all result in loss or impairment of vaginal structure and function. Researchers at Pitt developed a novel hydrogel biofabricated from porcine vaginal extracellular matrix (vECM) and its potential applications in the field of Urogynecology.
University of Pittsburgh researchers have developed EndoDx, a groundbreaking diagnostic tool that leverages machine learning to diagnose endometriosis (EM) early and non-invasively. This model predicts the presence and severity of endometriosis, offering a non-invasive alternative to surgical diagnosis. • Diagnostic tool for endometriosis.
University of Pittsburgh researchers have developed a sustained release vaginal film for the simultaneous protection against HIV and unintended pregnancy. Vaginal films have been shown to be an acceptable format for delivering pharmacologic actives. While vaginal films have been commercially used as immediate release dosage forms, this platform offers sustained drug delivery.
A new self-controlled vaginal film called HerShield empowers people with vaginas to protect themselves against genital herpes. • Delivery of probiotics and other agents for vaginal health. Comparison of the Pharmacokinetics and Pharmacodynamics of Single-Dose Tenofovir Vaginal Film and Gel Formulation (FAME 05).